Consulting communities on feedback of genetic findings in international health research: sharing sickle cell disease and carrier information in coastal Kenya by Marsh, V et al.
Marsh et al. BMC Medical Ethics 2013, 14:41
http://www.biomedcentral.com/1472-6939/14/41RESEARCH ARTICLE Open AccessConsulting communities on feedback of genetic
findings in international health research: sharing
sickle cell disease and carrier information in
coastal Kenya
Vicki Marsh1,2,3*, Francis Kombe1, Raymond Fitzpatrick4, Thomas N Williams1,2,5, Michael Parker3 and Sassy Molyneux1,2,3Abstract
Background: International health research in malaria-endemic settings may include screening for sickle cell disease,
given the relationship between this important genetic condition and resistance to malaria, generating questions
about whether and how findings should be disclosed. The literature on disclosing genetic findings in the context
of research highlights the role of community consultation in understanding and balancing ethically important
issues from participants’ perspectives, including social forms of benefit and harm, and the influence of access to
care. To inform research practice locally, and contribute to policy more widely, this study aimed to explore the
views of local residents in Kilifi County in coastal Kenya on how researchers should manage study-generated
information on sickle cell disease and carrier status.
Methods: Between June 2010 and July 2011, we consulted 62 purposively selected Kilifi residents on how
researchers should manage study-generated sickle cell disease findings. Methods drew on a series of deliberative
informed small group discussions. Data were analysed thematically, using charts, to describe participants’
perceptions of the importance of disclosing findings, including reasoning, difference and underlying values. Themes
were derived from the underlying research questions and from issues emerging from discussions. Data
interpretation drew on relevant areas of social science and bioethics literature.
Results: Perceived health and social benefits generated strong support for disclosing findings on sickle cell disease,
but the balance of social benefits and harms was less clear for sickle cell trait. Many forms of health and social
benefits and harms of information-sharing were identified, with important underlying values related to family
interests and the importance of openness. The influence of micro and macro level contextual features and
prioritization of values led to marked diversity of opinion.
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Conclusions: The approach demonstrates a high ethical importance in many malaria endemic low-to-middle
income country settings of disclosing sickle cell disease findings generated during research, alongside provision of
effective care and locally-informed counselling. Since these services are central to the benefits of disclosure, health
researchers whose studies include screening for sickle cell disease should actively promote the development of
health policy and services for this condition in situations of unmet need, including through the prior development
of collaborative partnerships with government health managers and providers. Community consultation can
importantly enrich ethical debate on research practice where in-depth exploration of informed views and the
potential for difference are taken into account.
Keywords: Kenya, Africa, Sickle cell disease, Community consultation, Genetic findings, Genetic and genomics
research, Deliberative methods, Empirical ethicsBackground
Sickle cell (SC) disease is a serious single gene disorder
common in many malaria endemic parts of Africa; areas
that account for three quarters of an estimated 300,000
to 500,000 children born with SC disease worldwide
every year [1]. The high prevalence stems from an evolu-
tionary link between the SC gene and resistance to mal-
aria, a feature that also underpins the common inclusion
of SC screening in health research in malaria endemic
settings where the gene may act as a risk factor. For ex-
ample, in the setting for this paper in Kilifi, where
around 1% children under one year of age have SC dis-
ease and 18% carry SC trait, assessment of SC status has
been included in descriptive and intervention studies on
malaria, pneumonia, Human Immunodeficiency Virus/
Acquired Immunodeficiency Syndrome (HIV/AIDS) and
malnutrition in young children as well as in studies on
SC disease. An ethical question may then arise about the
importance of sharing findings on sickle cell status gen-
erated during studies; an issue paradigmatic of more
general debates in the literature on researchers’ respon-
sibilities for disclosing study-generated genetic findings
with participants, including the additional challenges
presented where services for health problems related to
findings are not widely available.
SC disease, an autosomal recessive condition, is an
inherited abnormality of red blood cells. Affected children
inherit two copies of an abnormal haemoglobin gene, one
from each parent. For couples where both individuals carry
one copy of the abnormal gene, described as having SC trait
or being a carrier for SC disease, there is a 1 in 4 chance of
future children being affected by the disease. From a bio-
medical perspective, a high potential for benefit from shar-
ing research-generated SC disease findings stems from a
positive health impact of comprehensive forms of health
care. Without care, symptoms can be very severe and life
threatening, mainly resulting from obstruction to small
blood vessels, chronic anaemia, acute breakdown of blood
cells and increased risk of serious infection [2,3]. Althoughenvironmental and genetic factors influence severity, with-
out care many children in malaria endemic settings are
likely to die in their first few years of life [4,5]. In contrast,
quality of life is significantly improved where comprehen-
sive care programmes are in place, typically in high-income
settings [6,7], leading to a median adult survival of 48 years
[8]. SC trait is generally seen as a benign condition [9,10]
whose main implication is an increased future reproductive
risk for the disease [11].
From the literature, key features of the debate on the
general importance of sharing study-generated genetic
information with participants are the benefits to partici-
pants in practice, including social benefits such as
knowing about future reproductive risks [12]; the need
to include a wide range of views in understanding the
nature and importance of potential benefits [13]; and
the validity of testing processes. Over time, consensus
in guidelines on disclosure has moved towards
recommending greater openness [13], mainly drawing
on ethical principles of respect for autonomy of, and
maximising benefits for, participants [12]. For SC trait,
in addition to generating participants’ awareness of fu-
ture reproductive risks, an importance has been seen in
alerting the wider family to this risk, and respecting their
rights to ownership of genetic information [14]. Chal-
lenges to disclosure of SC disease findings arise where
services needed to generate benefits (such as specialist
knowledge, clinical care and counselling) are not avail-
able [15]; and, for both disease and trait, by the risks of
research being seen as a form of clinical service and is-
sues of research resource prioritisation [12]. Additional
risks for SC trait findings are that the health implications
will be misinterpreted, stigmatisation and - for children
screened - of undermining their autonomy [16]. While
the potential for benefit in sharing study-generated SC
findings is likely to be closely linked to the presence of
effective health services for the condition, these are not
widely available in many malaria-endemic settings, with
some localised exceptions [17,18]. The potential benefits
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depend on forms of ancillary care provided by re-
searchers [19].
Against this background, and building on on-going
community engagement activities within the research
programme [20,21], this paper reports on a study aiming
to inform research practice through exploring the views
of a diverse group of Kilifi residents on how researchers
should manage study-generated information on sickle
cell disease and carrier status. Community engagement
has been seen as essential to supporting ethical conduct
of research, particularly for international collaborative
research conducted in low-income settings [22] through
enabling research to be conducted in a way that is re-
spectful to individuals and communities and social value
to be maximized [23]. Towards these aims, community
consultation, as a form of community engagement, aims
to include ‘community voices’ in planning research, in-
cluding research questions and activities. At the same
time, there is unresolved debate on how consultation
should be undertaken, including how a community
should be defined, who might reasonably represent a
community, and how their voices might be listened to
and taken into account in practice [24-26]. The consult-
ation methods described in this study used an
information-sharing, deliberative approach. Although it
is not within the scope of this paper to assess the contri-
bution of this method to the literature on community
engagement, we aim to illustrate this contribution in
supporting policy decision making in research.
Methods
Study site
A detailed description of the KEMRI Wellcome Trust re-
search programme and its setting in Kilifi on the coast of
Kenya has been given elsewhere [27]. In summary, the
county includes rural and semi-urban populations of
around 1 million; subsistence farming is the primary liveli-
hood and between 55% and 65% households live below a
poverty line defined in relation to the costs of meeting basic
needs [28]. The study was conducted within the population
of 260, 000 people resident within the programme’s Health
and Demographic Surveillance System (KHDSS) that ac-
counts for around 80% of admissions to the County Refer-
ral Hospital [29]. The main population group are Mijikenda
[30]; 47% describe Christianity, 13% Islam and 24% trad-
itional beliefs as their faith system. During community en-
gagement planning surveys in 2005, 45% adults reported
inability to read a newspaper or letter, although free pri-
mary school education was introduced nationally in 2003.
In the research setting for this paper in Kenya, there is
a close collaboration between researchers at the KEMRI
Wellcome Trust Research programme and government
health providers at Kilifi County Referral Hospital thatincludes the provision of a dedicated weekly clinic for
people affected by SC disease, part of wider systematic
long-term research support provided to the community
through the County Health Management Team [31].
Given this availability of care, researchers in Kilifi gener-
ally disclose study-generated findings on SC disease to
affected families, but not on SC trait [32]. At the same
time, challenges have been experienced with low use of
the SC clinic and in providing the resources needed to
support disclosure, particularly for large scale studies. As
reported elsewhere [27] a particular challenge in
research-based SC disease screening in healthy children
was the likelihood of ‘diagnostic misconceptions’, where
the test is seen as health check for the benefit of the in-
dividual, similar to the more commonly described ‘thera-
peutic misconception’ of research [33].
Study population, sampling and data collection
63 residents participated in this study, detailed in Table 1.
A priori purposive sampling aimed to explore diversity
within the population, drawing on features of role, gen-
der and geographic residence (rural and urban). Partici-
pants included: i) Residents working full time within the
research programme (n=20), including Community Fa-
cilitators, Field Workers (staff supporting studies
through undertaking informed consent processes, inter-
views and some sample-taking), Data Entry Clerks and a
Scientist in training; ii) District Health Managers (n=4);
iii) Administrative leaders, Chiefs and Assistant Chiefs
(n=18); iv) KEMRI Community Representatives (KCRs)
(n=18), who are ‘typical’ residents selected by local com-
munities to support consultation on research-related
issues through regular or ad hoc meetings with commu-
nity liaison staff and/or researchers ; and v) Mothers of
affected children (n=3), not belonging to the above
groups. All groups included people of different ages, reli-
gions and educational status.
Participants were invited to attend one or two small
group discussions (3 to 6 people) to support an informed
deliberative process to assess elements of good practice
for information sharing on SC disease and trait [34-36]
across two stages. Stage one and two discussions were
held one week apart at local venues near to participants’
homes or, for staff members, at the research centre; and
using the participants’ language of choice (English, Ki-
swahili or local dialect). The first stage, based on partici-
patory processes, aimed to share information on:
 Prevalence, health implications and forms of
management for SC disease;
 SC disease inheritance, particularly transmission
across generations by healthy people with SC trait;
 Risks of future children being affected where both
parents have SC trait.






a SC disease history
Staff: Community facilitators 5 4:1 12-16y 14y 4C/1M No direct history
Staff: Field workers 12 10:2 12-14y 12y 10C/2M 1 field worker - sister has 2 children with
SCD
1 field worker - 2 affected children, 2 further
children died SCD
Staff: Othersb 3 0:3 12-16y 3C 1 data entry clerk - carrier, 2 brothers with
SCD, 1 died; carrier child
Health managers 4 3:1 16-18y 16y 4C No direct history
Chiefs/ assistant chiefs 18 16:2 7-14y 12y 17C/1M No direct history
KCRs: 5 chair/vice chairs; 4 secretary/vice
secretaries; 9 members
18 9:9 3-16y 8y 14C/4M 1 KCR rural area – 1 child with SCD
Community members: affected mothers 3 0:3 6-12y 6y 3C 2 with 2 affected children; 1 with 1 affected
child
aC= Christian; M = Muslim.
bTwo data entry clerks and one junior scientist.
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the first to explore perceptions of the importance of
sharing SC disease and SC trait findings, using two sce-
narios addressing these different forms of the condition.
Stage two discussions aimed to:
 Describe the perspectives of all participants as far as
possible;
 Explore reasoning using non-judgmental probes to
support reflection, including any emerging morally
relevant issues;
 Encourage expression of diversity of views;
 Pay attention to the voices of the most vulnerable
within the population, taken here as parents and
families of children with SC disease.
Data management and analysis
Field notes were made during and immediately after
meetings. Discussions were recorded, transcribed and
translated into English, including a total of 48.5 hours of
recordings. All translations were undertaken by note
takers present at the meetings, experienced staff in the
social science research group with fluency in local lan-
guages and English, and checked by FK. Debriefings
were held within the study team after each discussion,
and findings used to inform the on-going development
of the interview guide.
Data were managed using Microsoft Word applica-
tions, anonymised through coded identities. The analysis
used a modified form of framework analysis [37]. In this
study, following in-depth reading of transcripts, we de-
veloped a series of analysis charts to capture individual
and group level data under themes related to views on
the importance of sharing information on SC disease
and SC trait information, and underlying reasoning.Charts reflected the flow of debates including changing
views to identify individual positions emerging from de-
liberative discussions. Some themes used in charting
were derived from the underlying research questions,
based on probes used in discussions. These included
perceptions of the likely influence of information sharing
on health seeking practices, family relationships and the
interests and rights of different stakeholders, and the re-
sponsibilities of researchers. Themes were also identified
from issues emerging during discussions, including com-
mon underlying values, such as openness, truth telling
and family stability, and the conflation of SC disease
with HIV/AIDS. Analysis was primarily conducted by
VM, with support from the other authors, including
cross-checking and discussions around coding of data
within analysis charts. The varied backgrounds of the
authors, including bioethics, social science, public health
and community engagement were drawn upon to inform
the analysis. VM, SM and FK have lived and worked in
the research programme in Kilifi for more than 15 years.Ethical review
The study was approved by the Scientific Steering and
Ethical Review Committees in Kenya, and the OXTREC
committee at Oxford University. Approval included ver-
bal consent for participation, which was given by all par-
ticipants. The paper is published with the permission of
the director, KEMRI.Results
In this section, the first two sub-sections describe resi-
dents’ views on whether, why and how study-generated
information on SC disease and SC trait should be shared
with the parents of affected children. The remaining
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of context and underlying values.
Sharing information on sickle cell disease
The findings of this study confirmed those of earlier re-
search based on the experiences of directly affected fam-
ilies [32] of low levels of biomedical awareness of SC
disease in the community, and sometimes extreme levels
of distress experienced by some families in struggling to
understand what was happening to their child, and how
best to help them. Confusion was often compounded by
the nature of early symptoms of SC disease, being typic-
ally fleeting and varied, including episodes of severe un-
explained pain and crying, painful swelling of the hands,
feet or limbs, yellowness of eyes, fever and abdominal
swelling. From this and the earlier study, the main forms
of harm of ‘not knowing’ about SC disease were, there-
fore, seen as:
 The exacerbation of ill health and emotional distress
for the affected child where relatively ineffective
treatment was used, including traditional or faith-
based forms of healing;
 Emotional and economic costs to the family
associated with looking after the child, including loss
of income-generating activities for mothers;
 Forms of blame and conflict within families,
particularly affecting mothers blamed for causing
the condition in their child. An underlying feature
was the tendency for fathers to deny responsibility
for ill health in their children, instead placing blame
on mothers. Maternal blaming could take the form
of fault seen through direct mother-child
inheritance, curses or bewitchment; or through
claims of a wife’s sexual unfaithfulness and denial of
paternity.
Reasons for sharing SC disease information: Limiting harms
of ‘not knowing’
Against this background, participants in this study saw
sharing SC disease information during research as of
central importance in limiting future serious and avoid-
able harms for affected children and their families, by
optimising care-seeking and reducing the impact of
existing harmful ‘misconceptions’, rumours and suspi-
cions. In sharing information, participants saw the need
to give a full and convincing explanation of the cause of
SC disease, in addition to advice on management. Given
risks of gendered blaming in families, and a commonly
reported belief that effective biomedical care should be
curative, many participants particularly emphasised the
importance of sharing information on the lifelong nature
of the condition and its inheritance from both sides of
the family over many generations:“If the doctor does not explain [the cause and lifelong
nature of SC disease] in the end they might feel ‘what
are we trying to do, and the child is not getting
better? The doctor did not tell us anything except
always keep going [to clinic] if they don’t know they
will stop going in the end instead they will do other
things [alternative treatments] while the child
continues suffering.” (Female KCR with a child with
SC disease, KCR02/P2)“When I went to the doctor, the child was tested
and…we were told that there was a condition from
the father and me that caused the child to get that
thing. So when we came back home, other people
were saying that it was witchcraft…but, the two of us,
we knew because the doctor had explained to us, and
so we were not worried. So when the parents get
information, it removes the fear” (KCR mother of an
affected child, KCR02P2)
Some participants, in this and the earlier study [32],
described a specific risk that SC disease would be
confused with HIV/AIDS, prompted by the need for
long term treatment and the typical slim build of
people affected by both conditions. In this case, shar-
ing information on the latter would help to reduce
confusion:
“When they understand [about SC disease], they can
be able to remove that fear from their hearts because
some may misunderstand it, they take it this is a
disease like HIV/AIDS” (KCR01/P6)
These positive effects of information sharing were seen
for the families of affected children included in research.
They were also seen as likely to be helpful for other
affected family members, including those where the
condition was currently unrecognised. In addition,
residents felt information was likely to more widely
shared, given its perceived importance, and that posi-
tive effects would reach others in the community similarly
affected.
Reasons not to share SC disease information: The risks of
generating harm
Whilst there was broad agreement that information
should be shared, a number of arguments were proposed
against this, and for caution. First, explaining the occur-
rence of an inherited condition in the family might gen-
erate high, and sometimes unwarranted, levels of worry
and hopelessness:
“So I think it [sharing information] is important
though I have said it’s sensitive because…once you are
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because it is inherited, and so we are all going to have
sick children, you know, there is that traumatising
effect the parent might get” (male community
facilitator, IDI09P1).
Anxiety about the condition was also seen as poten-
tially undermining the parents’ emotional relationship
with their affected child and with each other. At an ex-
treme, anxiety about the risks to future children was
seen as prompting parents to consider separation:
“Okay now, for me, I can say that there will be many
separations… when it’s explained to them in detail the
way this is inherited…they can separate because they
will not want to have another child with a problem
like that.” (Female KCR, KCR01/P2)
Parental separation was seen as a particularly serious out-
come for mothers who lacked independent economic re-
sources, as would be likely for many in rural Kilifi. In this
traditionally patrilineal culture [38], mothers without inde-
pendent resources would be likely to have to move back to
their maternal homes where economic and social support
might not be forthcoming [32]. The position of a chronic-
ally sick child accompanying her mother to the maternal
home was seen as particularly fragile, given the costs of
health care. All the mothers of children with SC disease in
this consultation were greatly concerned about the impact
of parental separation on a mother and child. At the same
time, a few residents saw a potential benefit of separation
where both parents had independent livelihoods:
“…and if the worst comes to the worst and the family
breaks up…if this man decides to marry another wife
maybe he can get one who is not a carrier, and the
lady can also get a man who is not a carrier, and they
start very fresh lives.” (Female field worker, IDI07/P4)
Although explaining parents’ individual genetic roles was
seen as important to address paternal denial of responsibil-
ity, paradoxically, this information also carried a risk of gen-
erating or increasing gendered blame in families. This risk
was sometimes very strongly articulated, and seen as occur-
ring where fathers continued to deny their roles, if informa-
tion was misinterpreted, or where information generated
doubts about paternity of the child. As before, the conse-
quences of maternal blame were seen as potentially serious
for the mother and child. This point remained controversial
across all groups, although most perceived the risks of gen-
dered blaming to be greater in the absence of a good ex-
planation about the roles of both parents than with this. All
the women with an affected child in these discussions sup-
ported this view:“Because even if you don’t tell them, if they are going
to divorce, they will divorce…[for example thinking]
‘this woman is evil, every time she gives birth it’s a
sick child, maybe they [family] have evil spirits, so no!
You go to your home, you can even take the child, I
don’t need the child!’ But…if they will have been told,
they will understand.” (KCR with an affected child,
KCR01/P5)
Sharing information on sickle cell trait
As for SC disease, many residents felt that study-
generated information on SC trait should be shared with
families, but with greater differences and shifting of
opinions as new points of view were put forwards and
considered. Reasons not to share information on SC trait
were more commonly and strongly voiced than any
raised in support of withholding any type of information
on SC disease. A major influence was recognition of the
current lack of public access to SC disease screening for
healthy individuals, as described in the following
sections.
Reasons to share information on SC trait
There was almost complete agreement that individual
knowledge of SC trait would be very important to allow
families’ choice in reducing a child’s future reproductive
risks if screening for this condition was widely available.
In the absence of this service, many felt sharing SC trait
information would be less valuable. However, it was
often seen - sometimes strongly - that information
would help families to be prepared for this eventuality,
including understanding how to seek effective care:
“At least, s/he will be prepared [Kiswahili: amejiset].
At the time s/he comes to marry and if s/he has a
child like this, s/he will remember ‘eeh I was told, in
the past I was told.’” (Male KCR, KCR01/P4)
This benefit to families was often linked to a perceived
public health importance of creating wider awareness of
this genetic risk:
“He [the child] is fine, yes, he is fine, but… we have to
enlighten the parents that this problem may come up
in future…if this information is not known and the
condition ends up affecting those born in future, how
will this problem be solved? So I think they [parents]
need to be given the full information.”
(KCR, KCR02/P4)
In addition, some saw that sharing information on SC
trait could empower families to create a demand for
more and better SC disease services, both at a policy
and an individual level.
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As for SC disease, disadvantages were related to anxieties
thought likely to occur, including through misinterpreta-
tions. The key difference was that, for SC trait, these wor-
ries were seen as being generated without ‘good reason’,
given the inability to manage future reproductive risks by
screening a partner. At times, this view was strongly held,
including as a right ‘not to know’:
“I mean you will explain as well as you can, but later
you will leave that particular person worried. When
he [the child] comes to marry later, he will say that it
would have been better if I didn’t agree for him to be
tested…” (KCR, KCR02/P6)
“I just don’t think it’s worth knowing…if there is no
structure in place to say test the other person … I
would rather just stay the way I am [not be told].”
(Community facilitator, IDI09/P4)
Given the anxieties involved, some felt that SC trait
screening should target young adults, including before
marriage, but not infants or children. Others disagreed,
seeing that young people would be particularly vulner-
able to emotional upset from genetic screening:
“When you tell him directly that you have this then
he will be thinking a lot, and even consider
committing suicide because even when I get married
things won’t be good.” (Male KCR, KCR03/P4)
Concerns about unnecessary worry were compounded
by views that SC trait information could easily be
misinterpreted as having a direct impact on the child’s
health, either in the short or long term:
“…so they will remember all through that my child is
sick, not my child has a condition which needs a
person to make a good decision during marriage, but
they will just remember my child is sick…that thing
cannot move out of their mind” (Male community
facilitator, IDI09/P1)
One feature of the risk of misinterpreting the term ‘car-
rier’ was the common use of this term in referring to SC
trait and carrier status in HIV/AIDS, leading to conflation
between these types of ‘carriers’ or to the conditions them-
selves. A further local form of medicalisation of SC trait
was described as the potential for anxiety to lead some
people to seek traditional treatment to ‘remove’ the risk.
These views on the potential risks of sharing SC trait
information were not universally held. Some felt thatanxiety about SC trait was unlikely to be important in
practice; the experience of normal health in affected
children would lead parents to accept the condition as
non-harmful or forget the information in time. Accept-
ance would be helped by parents’ reflection on their
own health, since at least one parent must have SC trait;
and the much greater priority likely to be given to hard-
ships confronting many people in the community on a
daily basis.
A different and particularly key challenge in sharing SC
trait information - raised by relatively few residents, but
strongly influencing views in their groups - was the low
likelihood that parents would be able to accurately and sen-
sitively pass SC trait information on to their children in the
future, particularly given that this might happen in 10 or
more years’ time. A chief compared this situation to HIV/
AIDS control policy:
“Me I still disagree, they should not be told…we have
a programme in my area on HIV/AIDs infected
children. When a child reaches seven or eight years
you are supposed to disclose the news to the child,
but there is no parent who discloses the news to the
child…So it will be the same thing with sickle cell…”
(Chiefs 01/P3)
Within these discussions, others continued to feel that
parents were the right people to pass this sensitive infor-
mation on to children:
“They can help to prepare and explain this to the
child over time. They can also explain that being a
carrier is not an illness, particularly since they
themselves are also carriers.” (IDI01)
Finally, some individuals in some groups saw risks of stig-
matisation for children with SC trait, including difficulty in
finding marriage partners in future. Countering, others saw
that children and families had the option to keep carrier in-
formation confidential; and that carrier knowledge and
greater openness could work towards reducing stigmatisa-
tion. The latter point was made particularly strongly by all
mothers of affected children. As a community facilitator
said:
“I think if you borrow a leaf from what HIV/AIDS
campaign have been doing, the kind of education
which is being provided is fighting that stigma, yeah,
it has spread very much…” (IDI09/P3)
Additionally, in relation to risks of gendered forms
of blame and stigma in affected families, knowledge
and acceptance of carrier status before marriage was
seen to support mutual trust and help parents take
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outcome.
The influence of context on perceptions of outcomes of
information sharing
Diversity of opinion featured throughout the discussions
described so far, to a large extent related to recognition
of multiple influences on the way information sharing
might work out for different families. This context-
dependent feature of the impact of sharing genetic infor-
mation has been described in the literature as situated
processes of co-construction [39], illustrated here
through the interdependence seen for structural features
of context, family dynamics and the nature of informa-
tion shared.
Macro level influences
Cultural and socioeconomic circumstances Economic
status was seen to have a particularly important influ-
ence on the benefits of sharing information, particularly
for SC disease. For either parent, having independent
economic resources was thought to reduce the risks of
being ‘abandoned’, but this was particularly important
for mothers. For example, chiefs described that mothers
able to bring an income into the family would be more
likely to influence family decision making, and less
vulnerable to blaming by their husbands. Women in
the urban KCR group, particularly individuals with
high levels of education, talked positively of their
ability to manage their lives even if separation from a
partner occurred. Overall, mothers without an inde-
pendent livelihood were seen as vulnerable to harm
in situations of ‘not knowing’ and ‘knowing’ about
SC disease. Illustratively, a member of the District
Health Management Team spoke of this as a ‘path-
etic situation’.
The cultural practice of polygamy also provided an in-
fluence in the way some families might resolve anxieties
about future reproductive risks in Islamic and traditional
faiths where the practice is supported and amongst fol-
lowers of other religions. In these situations, the exist-
ence of strong emotional bonds within a family was seen
as a reason to choose polygamy in preference to
separation.
Many residents also raised a role for formal education
as an influence on the benefits of sharing information,
often based on an assumption that greater exposure to
schooling would reduce risks of misunderstanding gen-
etic information, a controversial point:
“The highly educated people are the most difficult to
explain to, but the ordinary people will listen and
think, because education is different to intelligence.”
(Male KCR, KCR01/P6)In general, increased schooling in women was gener-
ally related to greater potential for economic independ-
ence, and reduced vulnerability to blame and the harms
of family breakup, serving as a marker for valued forms
of development:
“For one, I think we are moving from the older days…
I think to be sincere more people have gone to school,
they can understand even the genetic part of this
information as opposed to long time ago, and I think
people who blame maybe the wife for the genetic
makeup - though there’s still a gap - but I don’t think
that’s so big” (Community facilitator, IDI09/P1).
Micro level influences
Individuals and family relationships Alongside de-
scriptions of the influence of culture and socioeconomic
factors, residents agreed that there was considerable
variation within families in the way that individuals re-
late to each other, seen as a very important influence on
the outcome of family disputes [40]. The most com-
monly described and important positive concepts were
those of trust and emotional commitment, with jealousy
as a counter. The likelihood of fathers accepting their
genetic role in SC disease, including having SC trait and
being the parent of an affected child, was seen as
dependent on the emotional bonds and levels of trust
already in place in the family. Where these existed, pa-
ternal denial, gendered blaming and separation were
much less likely.
To some extent, observed patterns of SC disease
within the family were thought to play into these inter-
pretations, since a common response to recognition of
an unknown illness would be to scrutinise extended
families on both sides over several generations to see
whether any patterns could be established suggesting
the origins of the problem [32]. Similar practices have
been described for genetic conditions within families
in high-income country settings [41]. However, there
was little agreement on the implications of particular
patterns. Explaining reproductive risks to young cou-
ples with one affected child might increase the risk of
family breakup, given that no other children would be
involved; but parents in this situation might not take
a theoretical future reproductive risk seriously. It
seems likely that patterns may be less important than
other contextual features, particularly the attitudes of
individual parents and the existence of trust, as de-
scribed previously.
Emerging underlying values
While differences of opinion were often based on the in-
fluence of macro and micro level features in different
families, tension was also associated with controversy in
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sions were prioritised. A generally dominant value was
the protection of vulnerable children and family stability,
seen as inter-dependent, and described here as a value of
‘family interests’. In addition, openness – often as a form
of empowerment – was highly valued by many partici-
pants. While these values are likely to have gained prom-
inence from the focus of these discussions on children
affected by a serious genetic condition, they played an
important role in strengthening convictions and con-
cerns through their alignment or tension, respectively,
within debates.Family interests
The interests of vulnerable children, their mothers
and families In weighing up the potential benefits and
disadvantages of sharing SC information described so
far, many residents placed the interests of children with
SC disease and their mothers, linked to stability and har-
mony in families, as their main priority. A lesser degree
of vulnerability for children with SC trait was generally
reflected in a less heated defence of their individual in-
terests; instead more controversy drew on the public
health importance of SC trait.
In the literature, the concept of family is complex. A
distinction has been made between two broad meanings:
the household or ‘aggregate or group of actual members
who are closely associated by living arrangement or by
commitment, for better or worse’; and the family in ab-
stract, including ‘the family line…whose boundaries ex-
tend over space and time’ [42](p35). The value of family
stability in these discussions seems to relate to the
former, and often referenced structural economic ar-
rangements focused on the parents, affected child, sib-
lings and other dependent family members. At the same
time, intrinsic values of the ‘actual family’ and its
stabilising role in wider family society were also
described:
“What I’m saying is…you cannot make this conflict
rise in that home, because by all, either right or
wrong…you have to make them live together.”
(Chiefs 02/P2)Openness and empowerment
A positive idea of the value of openness underpinned
many views on the benefits of sharing SC informa-
tion, as a form of empowerment through knowledge
for individuals and the wider community. For ex-
ample, individual families would be able to take more
control over their lives (impacting care of an affected
child), experience less blame and stigmatisation, and
be better able to manage future reproductive risks:“Information is power…so if they get the knowledge
[about SC disease], they will continue managing the
kids very well, ignoring the others, whatever the other
people will be saying.” (Male field worker, IDI07/P3)
At a community level, openness about SC disease and
SC trait was also linked to the potential for advocacy
and reducing stigmatisation, the latter often linked to
HIV/AIDS control policy:
“Ok…back in 1984, 1982, when the first AIDs cases
were discovered.... I think in this same case [of SC
disease]…many people don’t know or don’t
understand about it…Now we are living with HIV
patients.... it’s no longer an issue as it used to be.
[For SC disease] as time goes by…a few members
of the family will accept, and then later a few
members of the village accept, and then later on a
few members of the location accept…” (IDI07/P3)
Similarly, a field worker told the story of a mother
whose child had been found to have SC disease dur-
ing research, and whose attitude had changed from
an initial one of denial and anger to one of positively
seeking to influence community knowledge and atti-
tudes by becoming a local advocate for SC disease in
her village. The suggestion that knowledge could em-
power affected families or communities to lobby for
better SC disease services in the future also reflects a
community level benefit. At the scale of a specific
project, this may be difficult to imagine, but patient
advocacy and public pressure have in fact been the
driving force for SC disease programmes in many
parts of Africa where these exist, in the form of char-
itable foundations [18].
Finally, several residents described a potential nega-
tive impact of a lack of openness about SC trait in-
formation, reflecting on policies at that time for the
genomics study in Kilifi. The risk was of loss of trust
in researchers (and the research institution) by indi-
viduals or the wider community if it became known
that SC trait information had been withheld. Exam-
ples of ways this might happen included future SC
disease screening with a conflicting result, or the
birth of an affected child in a future generation of
the family:
“Maybe we may just say that we don’t want to displease
the parents, but then after that, yes, the kid will be a
carrier and nothing will change that…when he or she
marries another carrier, ok, ‘we were told that the kid
was negative, how did this come about? Or was there
something which was being hidden as to..?’ Ok, it will
bring some question marks.” (Field worker, IDI06/P1)
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In this study, we aimed to explore informed views of a
range of residents in Kilifi County in Kenya on how re-
searchers should manage information generated on SC
disease and trait during studies as a form of community
consultation. We sought to understand views on what
information should be shared and how, and with what
potential benefits, risks and other ethical implications, to
contribute to the development of policy. In this discus-
sion, we highlight key findings and their implications,
and lessons learned for methodology in community con-
sultation in this and similar settings.
Sharing study-generated information on SC disease and
SC trait
Overall, the consultation indicated a high ethical import-
ance of sharing study-generated information on SC dis-
ease in children with their families. Community
perceptions of benefit show the case for disclosure as
compelling based on strong and agreed views on the
likelihood of limiting probable and severe harms for
many participant children, their mothers and families.
This conclusion is underlined by research guidelines on
the disclosure of genetic findings that reference the im-
portance of taking account of clinical and social benefits
(or utility) of sharing information [13].
The study also illustrated the sensitivities involved in
sharing SC disease information, with risks of generating
unnecessarily high levels of anxiety in families and put-
ting sometimes extreme strain on parental relationships.
Any resulting parental separation was seen as engender-
ing very severe hardship for some mothers and affected
children. In addition, an aim of sharing information on
parental roles in SC disease to reduce risks of paternal
denial of responsibility for their child’s condition could
paradoxically increase these risks, depending on the in-
fluence of existing relationships, socioeconomic context
and the way in which information is shared. A specific
challenge was the risk of generating paternal requests
for individual screening to ‘test’ for paternity. Commu-
nity views on what researchers’ responsibilities might be
in this situation were mixed, but we have argued [43]
that researchers should not test parents since harms
likely to be caused by showing misattributed paternity,
even if in few cases, outweigh responsibilities to counter
paternal denial in this way.
In the case of SC trait, where the perceived harms
were seen as less immediate and severe, there was also
greater disagreement on the benefits of sharing informa-
tion. Disagreement and ambivalence were strongly
underpinned by the lack of public access to screening
for SC trait in healthy adults in Kenya, and by a series of
concerns, including: parents’ ability and willingness to
pass on genetic information to their children in future;the psychological effect of this information on affected
individuals; and risks of stigmatisation, including where
the word ‘carrier’ was conflated with the use of this term
in HIV/AIDS. In this way, a few participants supported a
right not to know about carrier status in these circum-
stances. At the same time, different forms of benefit
from sharing SC trait information were seen, including
the ability to create wider public awareness of SCD, such
that public advocacy could apply pressure for wider
screening services to be set up. A central benefit seen
was that of ‘preparedness’, with the potential to limit fu-
ture harms through better understanding of the condi-
tion. Relatedly, awareness of SC trait status within a
partnership before marriage was seen to have the poten-
tial to limit risks of parental separation and gendered
blame if an affected child was later conceived. In any
case, participants were concerned that failing to share
SC trait information, where this was known by re-
searchers, could undermine relationships between resi-
dents and researchers where this was seen as
‘withholding’ important information. One implication of
this diversity of opinion is that the concept of healthy
carrier status in SC disease - and for the potential for
this to be disclosed by research - should be shared dur-
ing the consent process, and participants given a choice
about accessing information on SC trait where this is
seen as helpful. A similar approach has been taken for
carrier findings during newborn SC disease screening
programmes in Ghana [9], and is recommended by the
European Society of Human Genetics [44].
An important challenge to views that study-generated
SC disease and trait information should be shared that
was not considered in depth during the consultation
comes from considering the resources, and appropriate-
ness, of researchers taking responsibility for supporting
counselling and clinical services for a lifelong health
condition of public health importance. Apart from argu-
ments about resource prioritisation in research, research
funding cycles are often incompatible with providing
lifelong services; and researchers taking on this role may
undermine that of Ministry of Health partners [15]. Re-
source arguments are particularly challenging for dis-
closure of SC trait findings, where the perceived benefits
are less urgent and certain than for SC disease, and re-
sources requirements to validate tests and provide coun-
selling are greater, given its higher prevalence (18% SC
trait vs. 1% SC disease prevalence in infants in Kilifi). In
this way, the findings highlight the challenge, described
in the literature on disclosing genetic findings, of balan-
cing the benefits of disclosure to individual study partici-
pants against the resources needed to support realisation
of these benefits [15,45], in this case through ensuring
provision of SC services, including clinical care and
counselling. On this basis, while the absence of effective
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searchers’ responsibilities for disclosure in some in-
stances, our findings highlight the moral challenges of
failing to share study-generated information on SC dis-
ease. Rather, the ethical importance of limiting harm in
this situation, together with the public health nature of
SC disease, underlines the importance of researchers
working in prior partnerships with government health
authorities to ensure that - as far as possible - disclosure
and services support the long term interests of study
participants.
Learning about community consultation
Community consultation is widely recognised as import-
ant in supporting ethical practice in many types of
research, particularly to take account of potentially
conflicting principles emerging from theory or practice
[46,47]. There is less published experience or guidance on
approaches to community consultation, including on ways
of consulting on technical aspects of research that are not
necessarily familiar to potential participants [25] . Our ex-
periences suggest that building information-sharing activ-
ities into the consultation was essential to the complexity
of discussions, given low awareness in the community of
many ethically important biomedical aspects of SC disease
and its inheritance. In addition, using deliberative
methods - including re-visiting issues over time - facili-
tated a strong and reflective engagement, and generated
diverse and detailed accounts of the views and values of
residents.
Diversity was largely generated in two ways: firstly, by
participants recognising inter-related individual and con-
textual influences on the likely impact of information
sharing; and, secondly, by participants’ different ways of
prioritising underlying values. The depth of exploration
gave insights into the central importance attached to
family interests and policies of openness; alignment of
these values often underpinned strength of opinion and
levels of agreement. Similarly, tension between these
values or their prioritisation in specific situations lay be-
hind much disagreement. The ethical implications of
both forms of diversity suggests that community con-
sultation should be based on carefully accounting for
difference, including in the voices listened to, the sharing
of information to support debate and the use of methods
that explore reasoning and reflection over time, without
resort to consensus building.
At the same time, further research on these and other
methods for consultation are important to strengthen
understanding of the potential contribution of these
findings to policy, including how typical these ‘commu-
nity voices’ are, whether and how wider community ac-
countability should be sought and whether views based
on the assimilation of relatively new understandingsmight importantly continue to develop over time. In par-
ticular, an iterative approach involving feeding back of
the findings to community and other national research
stakeholders in Kenya would be important in developing
wider policy [48].
Conclusions
This study has shown the high ethical importance and
the sensitivities of sharing study-generated information
on SC disease in children in Kilifi and other similar set-
tings, including the potential to limit harms that may
otherwise be very severe for affected children and their
families. In this consultation, arguments for sharing SC
trait information created greater controversy, and were
less compelling in terms of the nature and probability of
harms potentially limited. The extent of diversity in
views on sharing carrier status suggests that disclosure
policies that support individual choice would import-
antly maximize the possibility of individual benefit. The
public health nature of SC disease and the ethical im-
portance of limiting harm in these situations emphasise
the importance of researchers whose studies include SC
screening working in prior partnerships with govern-
ment health authorities to ensure that - as far as possible -
disclosure and services support the long term interests of
study participants.
Theoretical questions on approaches to normative
analysis of empirical findings from community consult-
ation on health research practice, and the role of in situ
empirical debates, remain far-reaching [49] and have not
been addressed in this paper. In fact, there remains a
gap in understanding which data collection and analysis
methods would be most effective in community consult-
ation on health research, particularly for technical and
unfamiliar aspects of studies [25]. Within these limita-
tions we conclude that approaches using deliberative
discussion and drawing on shared information, norma-
tive reflection and an exploration of the potential for dif-
ference can importantly enrich ethical debates on good
practice.
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